According to Ascendis Pharma 's latest financial reports the company's total assets are $0.91 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.91 B | -21.79% |
2022-12-31 | $1.16 B | -5.01% |
2021-12-31 | $1.22 B | 1.95% |
2020-12-31 | $1.20 B | 58.97% |
2019-12-31 | $0.75 B | 107.76% |
2018-12-31 | $0.36 B | 44.07% |
2017-12-31 | $0.25 B | 26.58% |
2016-12-31 | $0.20 B | 38.87% |
2015-12-31 | $0.14 B | 101.92% |
2014-12-31 | $71.35 M | 93.52% |
2013-12-31 | $36.87 M | 9.72% |
2012-12-31 | $33.6 M | 13.64% |
2011-12-31 | $29.57 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Akebia Therapeutics AKBA | $0.24 B | -73.52% | ๐บ๐ธ USA |
Affimed
AFMD | $0.12 B | -86.06% | ๐ฉ๐ช Germany |
Advaxis ADXS | $6.98 M | -99.24% | ๐บ๐ธ USA |